Gillian C Ivers Read Clovis Oncology, Inc. (CLVS) insider trading activity

Gillian C Ivers Read is Officer of Clovis Oncology, Inc.. Currently has a direct ownership of 293,612 shares of CLVS, which is worth approximately $26,425. The most recent transaction as insider was on Nov 02, 2022, when has been sold 3,681 shares (Common Stock) at a price of $0.98 per share, resulting in proceeds of $3,607. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 294K

0% 3M change

0% 12M change

Total Value Held $26,425

GILLIAN C IVERS-READ Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 02 2022	SELL Open market or private sale	$3,607 $0.98 p/Share	3,681 Reduced 1.24%	293,612 Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	-	8,374 Added 2.75%	295,618 Common Stock
Sep 02 2022	SELL Open market or private sale	$2,681 $1.2 p/Share	2,234 Reduced 0.77%	288,919 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	5,063 Added 1.71%	291,153 Common Stock
Aug 02 2022	SELL Open market or private sale	$5,551 $1.46 p/Share	3,802 Reduced 1.31%	286,090 Common Stock
Aug 01 2022	BUY Exercise of conversion of derivative security	-	8,374 Added 2.82%	288,190 Common Stock
Jun 02 2022	SELL Open market or private sale	$1,489 $0.64 p/Share	2,327 Reduced 0.82%	281,518 Common Stock
Jun 01 2022	BUY Exercise of conversion of derivative security	-	5,062 Added 1.75%	283,845 Common Stock
May 02 2022	SELL Open market or private sale	$7,354 $1.97 p/Share	3,733 Reduced 1.32%	278,783 Common Stock
May 01 2022	BUY Exercise of conversion of derivative security	-	8,374 Added 2.9%	280,845 Common Stock
Mar 02 2022	SELL Open market or private sale	$20,140 $1.87 p/Share	10,770 Reduced 3.78%	274,142 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	20,938 Added 6.85%	284,558 Common Stock
Feb 02 2022	SELL Open market or private sale	$8,617 $1.94 p/Share	4,442 Reduced 1.65%	263,974 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	-	8,375 Added 3.05%	266,427 Common Stock
Dec 02 2021	SELL Open market or private sale	$912 $3.0 p/Share	304 Reduced 0.12%	260,041 Common Stock
Dec 01 2021	BUY Exercise of conversion of derivative security	-	687 Added 0.26%	260,345 Common Stock
Nov 02 2021	SELL Open market or private sale	$16,817 $4.55 p/Share	3,696 Reduced 1.4%	259,658 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	-	8,374 Added 3.1%	261,699 Common Stock
Sep 02 2021	SELL Open market or private sale	$1,487 $4.89 p/Share	304 Reduced 0.12%	254,980 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	-	688 Added 0.27%	255,284 Common Stock
Aug 03 2021	SELL Open market or private sale	$17,752 $4.82 p/Share	3,683 Reduced 1.43%	254,596 Common Stock
Aug 01 2021	BUY Exercise of conversion of derivative security	-	8,374 Added 3.16%	256,630 Common Stock
Jun 03 2021	SELL Open market or private sale	$1,593 $5.63 p/Share	283 Reduced 0.11%	249,905 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	-	687 Added 0.27%	250,188 Common Stock
May 04 2021	SELL Open market or private sale	$21,894 $5.54 p/Share	3,952 Reduced 1.56%	249,501 Common Stock

GCI

Gillian C Ivers Read

Officer

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLVS shares.

Notify only if

Value

Insider Trading

Get notified when an Clovis Oncology, Inc. insider buys or sells CLVS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Clovis Oncology, Inc.

Track Activities on CLVS

Account